Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bausch & Lomb launches IOL (intraocular lens) insertion system:

This article was originally published in Clinica

Executive Summary

Bausch & Lomb is to launch in May 2003 an intraocular lens (IOL) insertion system designed to allow cataract surgeons to perform less invasive surgery and, thus, speed up patient recovery. The SofPort system, which the company claims is the only integrated, single-use, single-handed planar delivery IOL insertion device, allows an IOL to be introduced through a sub-3.0mm incision. The proprietary planar delivery method minimises the amount of lens unfolding typically encountered with traditional delivery systems, says the firm, which plans to launch the product in the US first, followed by selected world markets.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT061934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel